Viewing StudyNCT06344416



Ignite Creation Date: 2024-05-06 @ 8:20 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06344416
Status: RECRUITING
Last Update Posted: 2024-04-03
First Post: 2024-03-21

Brief Title: Open Label Controlled Post Marketing Registry Study of Ribociclib Ribo Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
Sponsor: Dosentrx Ltd
Organization: Dosentrx Ltd

Conditions & Keywords Data

Conditions:
Name
Any Solid Oral Medication
Keywords:
Name View
Solid oral medication View